Delivery Order SPE2DB22D3016-SPE2DB25FATX8
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,952.62 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,909,307 units of Ondansetron HCL 4 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,602.89, is for the delivery of 4,561,059,478 units of Ondansetron ODT 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.55 firm fixed-price delivery order is for the supply of 4,568,188,809 units of the prescription medication Ondansetron HCL 4 MG Tablet, with a completion date of May 9, 2025. The contract is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,566.08 for the supply of 4,565,520,865 units of the medication ondansetron hydrochloride 4 mg tablets. The contract is a firm fixed price agreement with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 21, 2024 and was awarded on August 20, 2024. This delivery order is likely part of a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,538.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg Tablets in quantities of 30 per tablet, with a completion date of February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,525.27 Firm Fixed Price Delivery Order is for the provision of 4,565,495,880 units of the medication Ondansetron HCL 4 mg Tablet, with a period of performance through August 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,594.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of 4,567,944,669 units of the medication Ondansetron HCL 4 mg Tablet in 30-count packages. The contract has a firm fixed-price pricing type and an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,849.36 firm fixed-price delivery order is for 4,566,250,238 units of the medication ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of October 29, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,228.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2006|SPE2DB25FW0LP) for the supply of 4,568,092 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 1, 2025 and is a firm fixed-price arrangement. This award is not associated with a set-aside program and is part of a...